India to conduct Russian vaccine's Phase 3 trials?

Moscow-based Gamaleya Research Institute of Epidemiology and Microbiology will now submit comprehensive data on the safety and efficacy of the Russian vaccine candidates to the Indian authorities,

Read The Rest : By timesofindia

Disclaimer : We make no assurance about the completeness and accuracy of the content of this website. All news on this website is collected from various sources hence information may or may not be true. Bollywood charcha does not verify the reliability of the content published. We do not accept any accountability for loss or damage occurred as a result of reliability on the content of this website.